+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

A Neutralizing Prolactin Receptor Antibody Whose In Vivo Application Mimics the Phenotype of Female Prolactin Receptor-Deficient Mice

A Neutralizing Prolactin Receptor Antibody Whose In Vivo Application Mimics the Phenotype of Female Prolactin Receptor-Deficient Mice

Endocrinology 156(11): 4365-4373

The prolactin receptor (PRLR) has been implicated in a variety of physiological processes (lactation, reproduction) and diseases (breast cancer, autoimmune diseases). Prolactin synthesis in the pituitary and extrapituitary sites is regulated by different promoters. Dopamine receptor agonists such as bromocriptine can only interfere with pituitary prolactin synthesis and thus do not induce a complete blockade of PRLR signaling. Here we describe the identification of a human monoclonal antibody 005-C04 that blocks PRLR-mediated signaling at nanomolar concentrations in vitro. In contrast to a negative control antibody, the neutralizing PRLR antibody 005-C04 inhibits signal transducer and activator of transcription 5 phosphorylation in T47D cells and proliferation of BaF3 cells stably expressing murine or human PRLRs in a dose-dependent manner. In vivo application of this new function-blocking PRLR antibody reflects the phenotype of PRLR-deficient mice. After antibody administration female mice become infertile in a reversible manner. In lactating dams, the antibody induces mammary gland involution and negatively interferes with lactation capacity as evidenced by reduced milk protein expression in mammary glands and impaired litter weight gain. Antibody-mediated blockade of the PRLR in vivo stimulates hair regrowth in female mice. Compared with peptide-derived PRLR antagonists, the PRLR antibody 005-C04 exhibits several advantages such as higher potency, noncompetitive inhibition of PRLR signaling, and a longer half-life, which allows its use as a tool compound also in long-term in vivo studies. Therefore, we suggest that this antibody will help to further our understanding of the role of auto- and paracrine PRLR signaling in health and disease.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 057033817

Download citation: RISBibTeXText

PMID: 26284426

DOI: 10.1210/en.2015-1277

Related references

Effect of the association time of in vivo bound prolactin on the [125I]prolactin receptor assays of female rat livers. Molecular and Cellular Endocrinology 11(2): 145-151, 1978

Effect of the association time in vivo bound prolactin on the iodine 125 prolactin receptor assays of female rat livers. Molecular and Cellular Endocrinology 11(2): 145-152, 1978

Prolactin-binding proteins: studies on prolactin antibody and the prolactin receptor. Dissertation Abstracts International, B Sciences and Engineering 45(8): 2542, 1985

Prolactin receptor signal transduction pathways and actions determined in prolactin receptor knockout mice. Biochemical Society Transactions 29(Pt 2): 48-52, 2001

Identification of JAK protein tyrosine kinases as signaling molecules for prolactin: Functional analysis of prolactin receptor and prolactin: Erythropoietin receptor chimera expressed in lymphoid cells. EMBO (European Molecular Biology Organization) Journal 13(11): 2583-2591, 1994

Induction of prolactin receptors by prolactin in the rat lung and liver demonstration of separate receptor and antibody entities. Molecular & Cellular Endocrinology 39(1): 21-30, 1985

Ligand-induced activation of prolactin receptor and a chimeric growth hormone receptor/prolactin receptor. FASEB Journal 9(6): A1414, 1995

The rabbit mammary gland prolactin receptor is tyrosine-phosphorylated in response to prolactin in vivo and in vitro. Journal of Biological Chemistry 270(10): 5136-5143, 1995

Body weight and fat deposition in prolactin receptor-deficient mice. Endocrinology 142(2): 532-537, 2001

Sex-dependent roles of prolactin and prolactin receptor in postoperative pain and hyperalgesia in mice. Neuroscience 253: 132-141, 2013

Osteoblasts are a new target for prolactin: analysis of bone formation in prolactin receptor knockout mice. Endocrinology 140(1): 96-105, 1999

The progesterone and estrogen modify the uterine prolactin and prolactin receptor expression of hyperprolactinemic mice. Gynecological Endocrinology 31(2): 148-151, 2015

Mammary gland prolactin receptor and pituitary prolactin secretion in lactating mice with different lactational performance. Acta Endocrinologica 88(1): 94-98, 1978